These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 8712713

  • 21. Clinical pharmacokinetics of oxaliplatin: a critical review.
    Graham MA, Lockwood GF, Greenslade D, Brienza S, Bayssas M, Gamelin E.
    Clin Cancer Res; 2000 Apr; 6(4):1205-18. PubMed ID: 10778943
    [Abstract] [Full Text] [Related]

  • 22. A comparative study of pharmacokinetics, urinary excretion and tissue distribution of platinum in rats following a single-dose oral administration of two platinum(IV) complexes LA-12 (OC-6-43)-bis(acetato)(1-adamantylamine)amminedichloroplatinum(IV) and satraplatin (OC-6-43)-bis(acetato)amminedichloro(cyclohexylamine)platinum(IV).
    Sova P, Mistr A, Kroutil A, Semerád M, Chlubnová H, Hrusková V, Chládková J, Chládek J.
    Cancer Chemother Pharmacol; 2011 Jun; 67(6):1247-56. PubMed ID: 20697713
    [Abstract] [Full Text] [Related]

  • 23. DNA-binding properties of novel cis- and trans platinum-based anticancer agents in 2 human ovarian carcinoma cell lines.
    Mellish KJ, Barnard CF, Murrer BA, Kelland LR.
    Int J Cancer; 1995 Sep 15; 62(6):717-23. PubMed ID: 7558420
    [Abstract] [Full Text] [Related]

  • 24. Efficient nucleotide excision repair of cisplatin, oxaliplatin, and Bis-aceto-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) platinum intrastrand DNA diadducts.
    Reardon JT, Vaisman A, Chaney SG, Sancar A.
    Cancer Res; 1999 Aug 15; 59(16):3968-71. PubMed ID: 10463593
    [Abstract] [Full Text] [Related]

  • 25. Pharmacokinetic and pharmacodynamic analysis of bis-acetato-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) administered once a day for five consecutive days: a phase I study.
    Kurata T, Tamura T, Sasaki Y, Fujii H, Negoro S, Fukuoka M, Saijo N.
    Jpn J Clin Oncol; 2000 Sep 15; 30(9):377-84. PubMed ID: 11095134
    [Abstract] [Full Text] [Related]

  • 26. Phase I clinical and pharmacokinetic study of the oral platinum analogue JM216 given daily for 14 days.
    Sessa C, Minoia C, Ronchi A, Zucchetti M, Bauer J, Borner M, de Jong J, Pagani O, Renard J, Weil C, D'Incalci M.
    Ann Oncol; 1998 Dec 15; 9(12):1315-22. PubMed ID: 9932162
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Intracellular biotransformation of platinum compounds with the 1,2-diaminocyclohexane carrier ligand in the L1210 cell line.
    Mauldin SK, Gibbons G, Wyrick SD, Chaney SG.
    Cancer Res; 1988 Sep 15; 48(18):5136-44. PubMed ID: 3409241
    [Abstract] [Full Text] [Related]

  • 30. Studies on the pharmacokinetics and metabolism of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum(IV) in the dog.
    Pendyala L, Cowens JW, Creaven PJ.
    Cancer Treat Rep; 1982 Mar 15; 66(3):509-16. PubMed ID: 7060038
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters.
    Samimi G, Howell SB.
    Cancer Chemother Pharmacol; 2006 Jun 15; 57(6):781-8. PubMed ID: 16170571
    [Abstract] [Full Text] [Related]

  • 37. In vitro binding of an orally active platinum antitumor drug, JM216 to metallothionein.
    Xing B, Zhu H, Shi Y, Tang W.
    Biometals; 2001 Mar 15; 14(1):51-7. PubMed ID: 11368275
    [Abstract] [Full Text] [Related]

  • 38. Mini-review: discovery and development of platinum complexes designed to circumvent cisplatin resistance.
    Kelland LR, Sharp SY, O'Neill CF, Raynaud FI, Beale PJ, Judson IR.
    J Inorg Biochem; 1999 Oct 15; 77(1-2):111-5. PubMed ID: 10626362
    [Abstract] [Full Text] [Related]

  • 39. Current status and future prospects for satraplatin, an oral platinum analogue.
    Choy H, Park C, Yao M.
    Clin Cancer Res; 2008 Mar 15; 14(6):1633-8. PubMed ID: 18347164
    [Abstract] [Full Text] [Related]

  • 40. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
    Mizojiri K, Okabe H, Sugeno K, Misaki A, Ito M, Kominami G, Esumi Y, Takaichi M, Harada T, Seki H, Inaba A.
    Arzneimittelforschung; 1997 Mar 15; 47(3):259-69. PubMed ID: 9105544
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.